Letter Regarding “Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study”

Letter Regarding “Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study”

Saved in:

Bibliographic Details
Main Authors:	Nanami Kosaka, MD, Yuki Kataoka, MD, MPH, DrPH
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	JTO Clinical and Research Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364324001309
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01)

Pre-immunotherapy alters stereotactic ablative radiotherapy-induced systemic T cell responses in early-stage NSCLC
by: Chao Liu, et al.
Published: (2025-02-01)

Temporal Trends in the Utilization and Survival Outcomes of Lobar, Segmental, and Wedge Resection for Early-Stage NSCLC, 2004 to 2020
by: Eden Z. Deng, BS, et al.
Published: (2025-03-01)

Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)

Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC
by: Francesca Lucibello, MD, et al.
Published: (2025-01-01)

Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC
by: Helena Bote-de Cabo, MD, et al.
Published: (2025-03-01)

Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
by: Yoshihito Kogure, MD, PhD, et al.
Published: (2025-03-01)

Access to Diagnostics and Treatment for People With Metastatic EGFR-Positive NSCLC: Lessons From Project PRIORITY
by: Jill Feldman, MA, et al.
Published: (2025-03-01)

Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?
by: J. Humberto Rodriguez-Quintero, MD, MPH, et al.
Published: (2025-01-01)

Racial Disparities in Cancer Guideline-Concordant Treatment Using Surveillance, Epidemiology, and End Results Data for Patients With NSCLC
by: Eric Ababio Anyimadu, MS, et al.
Published: (2025-01-01)

Changing Treatment and Metastatic Disease Patterns in Patients with EGFR Mutated NSCLC: An Academic Thoracic Medical Investigator’s Consortium Registry Analysis
by: Margaret Stalker, MD, et al.
Published: (2025-01-01)

Response to Letter to the Editor on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis”
by: Naita M. Wirsik, MD, et al.
Published: (2024-09-01)

Response to: Comment on Genetic Ancestry-Specific Molecular and Survival Differences in Admixed Breast Cancer Patients
by: Alexandra E. Hernandez, MD, MPH, et al.
Published: (2024-06-01)

Moderate Hypofractionated Post-Prostatectomy Radiotherapy (MYSTERY) Versus Conventionally Fractionated Post-Prostatectomy Radiotherapy (COPORT) for the Patients With Localized Prostate Cancer: The Protocol of a Prospective, Randomized Trial
by: Yiyin Liang MD, et al.
Published: (2025-01-01)

Frailty Is Associated With Decreased Survival in Adult Patients With Nonoperative and Operative Traumatic Subdural Hemorrhage: A Retrospective Cohort Study of 381,754 Patients
by: Evan N. Courville, MD, et al.
Published: (2023-12-01)

Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-small Cell Lung Cancer (NSCLC), a Randomized Controlled Study
by: Yifeng Gu MD, et al.
Published: (2025-01-01)

Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC
by: Christian Rolfo, MD, PhD, et al.
Published: (2025-01-01)

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
by: Arianna Marinello, MD, et al.
Published: (2025-03-01)

Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy
by: Jie Yang, et al.
Published: (2024-07-01)

Letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Matthew K. Wun
Published: (2025-01-01)

Cannabidiol Vaping–Associated Multifocal NSCLC in a 24-Year-Old Female: A Case Report
by: Mansi Barthwal, MD, et al.
Published: (2025-03-01)

Rapid food desensitization associated with omalizumab before oral immunotherapy
by: Bruna Giavina-Bianchi, MD, et al.
Published: (2025-02-01)

Corrigendum to ‘Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC’ [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]
by: Tsuyoshi Hirata, MD, et al.
Published: (2025-01-01)

Do Complications After Pancreatoduodenectomy Have an Impact on Long-Term Quality of Life and Functional Outcomes?
by: Ajami Gikandi, BA, et al.
Published: (2024-06-01)

Automated Patient-specific Quality Assurance for Automated Segmentation of Organs at Risk in Nasopharyngeal Carcinoma Radiotherapy
by: Yixuan Wang MD, et al.
Published: (2025-01-01)

Response to letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Marjory B. Brooks, et al.
Published: (2025-01-01)

Monitoring of Circulating Tumor DNA and Indication of De-Escalation Adjuvant Targeted Therapy for EGFR-Mutated NSCLC After Complete Resection
by: Song Dong, PhD, et al.
Published: (2025-01-01)

MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
by: Andrea Gaetano Allegra MD, et al.
Published: (2025-01-01)

A case of gangrenous cystitis with bilateral hydronephrosis 10 years after radiotherapy
by: Mariko Oniwa, et al.
Published: (2023-05-01)

First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
by: Laura Moliner, MD, et al.
Published: (2025-01-01)

Survival in Ecuadorian Patients with Prostate Cancer Clinically Treated with Radiotherapy and Chemotherapy
by: Alberto Sánchez Garrido, et al.
Published: (2024-01-01)

Letter regarding “Peripheral and intestinal T lymphocyte subsets in dogs with chronic inflammatory enteropathy”
by: Matthew K. Wun
Published: (2025-01-01)

Oral Cavity Squamous Cell Carcinoma: Impact of Clear Margin Distance on Locoregional Control in Patients Undergoing Postoperative Radiotherapy
by: Erkan Topkan MD, et al.
Published: (2025-02-01)

Superstition in Surgery: A Population-Based Cohort Study to Assess the Association Between Surgery on Friday the 13th and Postoperative Outcomes
by: Sanjana Ranganathan, MBE, et al.
Published: (2024-03-01)

E-Cigarette Use and Use of Evidence-Based Smoking Cessation Methods Among American Indian Cigarette Smokers: A Cross-Sectional Analysis
by: Ashley L. Comiford, DrPH, et al.
Published: (2025-04-01)

Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC
by: Evgenia Taranova, et al.
Published: (2025-01-01)

Long-Term Outcomes of Robotic Versus Laparoscopic Total Mesorectal Excisions: A Propensity-Score Matched Cohort study of 5-year survival outcomes
by: Rauand Duhoky, MsC, et al.
Published: (2024-06-01)

Malnutrition risk, weight loss, and subsequent survival in patients listed for heart transplantation
by: Tae Kyung Yoo, MD, MS, et al.
Published: (2025-02-01)

Comment on Genetic Ancestry-Specific Molecular and Survival Differences in Admixed Breast Cancer Patients
by: Eudora Olsen, BA, et al.
Published: (2024-03-01)